NK Cells Market Report

NK Cells Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Dec 29, 2019
  • PAGES：208
  • REPORT CODE：GMM415938
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide NK Cells market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.6% during the forecast period.

    This report presents the market size and development trends by detailing the NK Cells market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the NK Cells market will be shown in this report. In short, this report will comprehensively reveal the characteristics of NK Cells industry and will help you to build a panoramic view of the industrial development.

    NK Cells Market, By Type:

    • Mogamulizumab

    • Lorvotuzumab Mertansine

    • Others

    NK Cells Market, By Application:

    • Cancer

    • Cardiovascular Diseases

    • Others

    Some of the leading players are as follows:

    • Innate Pharma SA (France)

    • Chipscreen Biosciences (China)

    • Bristol-Myers Squibb (USA)

    • NKT Therapeutics (USA)

    • Affimed NV (Netherlands)

    • Altor BioScience Corporation (USA)

    • Takeda Pharmaceutical (Japan)

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 NK Cells Market: Technology Type Analysis

    • 4.1 NK Cells Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 NK Cells Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Mogamulizumab

      • 4.3.2 Lorvotuzumab Mertansine

      • 4.3.3 Others

    5 NK Cells Market: Product Analysis

    • 5.1 NK Cells Product Market Share Analysis, 2018 & 2026

    • 5.2 NK Cells Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 NK Cells Market: Application Analysis

    • 6.1 NK Cells Application Market Share Analysis, 2018 & 2026

    • 6.2 NK Cells Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Cancer

      • 6.3.2 Cardiovascular Diseases

      • 6.3.3 Others

    7 NK Cells Market: Regional Analysis

    • 7.1 NK Cells Regional Market Share Analysis, 2018 & 2026

    • 7.2 NK Cells Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Innate Pharma SA (France)

      • 9.1.1 Innate Pharma SA (France) Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Chipscreen Biosciences (China)

      • 9.2.1 Chipscreen Biosciences (China) Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Bristol-Myers Squibb (USA)

      • 9.3.1 Bristol-Myers Squibb (USA) Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 NKT Therapeutics (USA)

      • 9.4.1 NKT Therapeutics (USA) Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Affimed NV (Netherlands)

      • 9.5.1 Affimed NV (Netherlands) Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Altor BioScience Corporation (USA)

      • 9.6.1 Altor BioScience Corporation (USA) Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Takeda Pharmaceutical (Japan)

      • 9.7.1 Takeda Pharmaceutical (Japan) Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

     

    The List of Tables and Figures (Totals 107 Figures and 155 Tables)

    • Figure Mogamulizumab NK Cells market, 2015 - 2026 (USD Million)

    • Figure Lorvotuzumab Mertansine NK Cells market, 2015 - 2026 (USD Million)

    • Figure Others NK Cells market, 2015 - 2026 (USD Million)

    • Figure Cancer market, 2015 - 2026 (USD Million)

    • Figure Cardiovascular Diseases market, 2015 - 2026 (USD Million)

    • Figure Others market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America NK Cells market, by country, 2015 - 2026 (USD Million)

    • Table North America NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table North America NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table North America NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table U.S. NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table U.S. NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Canada NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Canada NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Europe NK Cells market, by country, 2015 - 2026 (USD Million)

    • Table Europe NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Europe NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Europe NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table U.K. NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table U.K. NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Germany NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Germany NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table France NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table France NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Italy NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Italy NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Spain NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Spain NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific NK Cells market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table China NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table China NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Japan NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Japan NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table India NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table India NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Latin America NK Cells market, by country, 2015 - 2026 (USD Million)

    • Table Latin America NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Latin America NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Latin America NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Brazil NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Brazil NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Mexico NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Mexico NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Argentina NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Argentina NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table MEA NK Cells market, by country, 2015 - 2026 (USD Million)

    • Table MEA NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table MEA NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table MEA NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table South Africa NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table South Africa NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria NK Cells market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria NK Cells market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria NK Cells market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Innate Pharma SA (France) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Chipscreen Biosciences (China) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bristol-Myers Squibb (USA) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table NKT Therapeutics (USA) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Affimed NV (Netherlands) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Altor BioScience Corporation (USA) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Takeda Pharmaceutical (Japan) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US